Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036859
Filing Date
2020-08-05
Accepted
2020-08-05 16:31:17
Documents
71
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q asmb-10q_20200630.htm   iXBRL 10-Q 2897195
2 EX-31.1 asmb-ex311_13.htm EX-31.1 18198
3 EX-31.2 asmb-ex312_10.htm EX-31.2 18123
4 EX-32.1 asmb-ex321_15.htm EX-32.1 8024
5 EX-32.2 asmb-ex322_8.htm EX-32.2 8117
  Complete submission text file 0001564590-20-036859.txt   10355136

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA asmb-20200630.xsd EX-101.SCH 54243
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asmb-20200630_cal.xml EX-101.CAL 54065
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asmb-20200630_def.xml EX-101.DEF 180521
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20200630_lab.xml EX-101.LAB 415222
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20200630_pre.xml EX-101.PRE 328249
11 EXTRACTED XBRL INSTANCE DOCUMENT asmb-10q_20200630_htm.xml XML 2367114
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 201078066
SIC: 2834 Pharmaceutical Preparations